Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2027 346

  1. Study completion Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06399835

  2. Primary completion Evaluation of the InterFACE-AR System for Cardiopulmonary Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06411327

  3. Primary completion The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06471699

  4. Study completion STunning in Acute Myocardial Infarction - BAS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06562582

  5. Primary completion STunning in Acute Myocardial Infarction - BAS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06562582

  6. Study completion Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06572085

  7. Primary completion Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06572085

  8. Study completion A Prospective Randomized Trial of External Vein Graft Support in Surgical Myocardial Revascularization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06629701

  9. Primary completion A Prospective Randomized Trial of External Vein Graft Support in Surgical Myocardial Revascularization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06629701

  10. Study completion The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06648174

  11. Primary completion The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06648174

  12. Primary completion Early Amiodarone in Shockable Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06680869

  13. Study completion Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06683040

  14. Primary completion Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06683040

  15. Study completion Personalized Evaluation of Susptected Myocardial Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06708000

  16. Primary completion Personalized Evaluation of Susptected Myocardial Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06708000

  17. Study completion Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06787430

  18. Primary completion Using AI Systems to Optimize the Clinical Outcome of Stroke Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06828679

  19. Study completion Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant PFA Balloon for the Treatment of AF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06828939

  20. Study completion Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06841965

  21. Study completion Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06841978

  22. Study completion Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06853535

  23. Primary completion Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06901960

  24. Primary completion DCB for CAD With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07009938

  25. Study completion Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07032311

  26. Primary completion Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07045142

  27. Study completion UHF ECG in LBBB and Response to CRT Prediction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07057544

  28. Primary completion UHF ECG in LBBB and Response to CRT Prediction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07057544

  29. Primary completion Pulsed Field Ablation vs. Cryoballoon Ablation in Patients With Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07064616

  30. Study completion Clinical Study on the Efficiency of Rapid Arrhythmia Mapping Using EasyStars™ High Density Mapping Catheter Applications Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07079813

  31. Primary completion Clinical Study on the Efficiency of Rapid Arrhythmia Mapping Using EasyStars™ High Density Mapping Catheter Applications Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07079813

  32. Study completion Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07088523

  33. Study completion Randomized a Clinical Trial With Medical Device in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07113184

  34. Study completion Electroacupuncture and rTMS for Post-Stroke Motor Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07113990

  35. Study completion Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07121088

  36. Study completion Phrenic Nerve Stimulation for Reducing Ventilation Duration in Acute Cerebral Infarction: A Multicenter Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07133932

  37. Primary completion Phrenic Nerve Stimulation for Reducing Ventilation Duration in Acute Cerebral Infarction: A Multicenter Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07133932

  38. Study completion Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07134712

  39. Primary completion Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07134712

  40. Primary completion Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07141303

  41. Study completion Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07173712

  42. Study completion FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07181135

  43. Primary completion FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07181135

  44. Study completion Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07203625

  45. Primary completion Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07203625

  46. Study completion A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07220538

  47. Primary completion A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07220538

  48. Primary completion Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07222813

  49. Primary completion Resuscitation Enhancement to Avoid Rearrest Through Evidence-based Strategies in Prehospital Post-resuscitation Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07239908

  50. Primary completion DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07241897

  51. Primary completion Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07244003

  52. Study completion Central Haemodynamics and Pacing for AV Block Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07276490

  53. Primary completion Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07279987

  54. Primary completion CLEAR Trial: CA330 Cytokine Adsorption Column for Anticoagulant/Antiplatelet Patients in Non-Elective CPB Surgery. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07284199

  55. Primary completion Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07296484

  56. Study completion Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07357987

  57. Primary completion CAS for Stenosis With High-risk Features for CEA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07370246

  58. Study completion VR Training to Improve Postoperative Cognitive Function in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07370844

  59. Primary completion Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07383155

  60. Primary completion Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07389460

  61. Primary completion Foundation Model for Post-MI Cardiovascular Event Alert Using Huawei Watch Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07395648

  62. Study completion CGM for Insulin-Treated T2DM During Post-Discharge Transition Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07414277

  63. Study completion A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07417306

  64. Primary completion A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07421297

  65. Study completion Effect of an Oral Neuromuscular Training Device on Dysphagia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07451028

  66. Primary completion Effect of an Oral Neuromuscular Training Device on Dysphagia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07451028

  67. Study completion Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07485075

  68. Primary completion Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07485075

  69. Study completion AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07491029

  70. Study completion Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07499154

  71. Study completion Intra-arterial Methylprednisolone After Endovascular Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07516522

  72. Primary completion Intra-arterial Methylprednisolone After Endovascular Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07516522

  73. Primary completion Restoring Sinus Rhythm Using Dual-Shock Technique in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07560644

  74. Study completion Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction(ELASTIC) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07563673

  75. Study completion Evaluation of Balloon Guide Catheter as Proximal Protection During Carotid Artery Stenting (EMBO-PROTECT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07576790

  76. Study completion Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07583173

  77. Primary completion Pro-urokinase for Extended-Window Posterior Circulation Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07617870

  78. Study completion A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07647133

  79. Study completion The Clinical Outcomes and Therapeutic Effects in Patients With Cardiac Implantable Electronic Device-detected Subclinical and Clinical Atrial Fibrillation. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07649109

  80. Primary completion The Clinical Outcomes and Therapeutic Effects in Patients With Cardiac Implantable Electronic Device-detected Subclinical and Clinical Atrial Fibrillation. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07649109

  81. Study completion A Study of Probiotics in Patients With Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07651332

  82. Study completion Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07667517

  83. Study completion A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07754825

  84. Primary completion A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07754825

  85. Study completion Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07796217

  86. Study completion Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07852988

  87. Primary completion Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07852988

  88. Study completion Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07889531

  89. Primary completion Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07889531

  90. Study completion TRADENT Scoring Balloon Versus Non-scoring Balloon for Lesion Preparation in DCB-Based Coronary Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07899021

  91. Study completion Study of the Safety and Efficacy of Prenofitol Tablets Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07908433

  92. Primary completion Study of the Safety and Efficacy of Prenofitol Tablets Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07908433

  93. Study completion Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07908875

  94. Primary completion Evaluating a Digital Aid to Improve ICD Decisions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07913204

  95. Primary completion Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932145

January 2028 86

  1. Study completion Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03496883

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion Smartphone-based Balance Assessment System for Chronic Stroke Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04040101

  2. Study completion Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04200781

  3. Primary completion Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04200781

  4. Study completion Wearable Devices for Secondary Prevention of Ischemic Stroke Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04282993

  5. Primary completion Asian Diabetes Outcomes Prevention Trial Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04286399

  6. Study completion Procedural Outcomes of Percutaneous PDA Closure: Comparative Study Between Different Devices. Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04303793

  7. Primary completion Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04667598

  8. Study completion Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04702490

  9. Study completion GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients. Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04942756

  10. Primary completion GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients. Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04942756

  11. Study completion Effect of Levosimendan on miRNAs Regulation in the Failing Hearts Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04950569

  12. Primary completion Effect of Levosimendan on miRNAs Regulation in the Failing Hearts Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04950569

  13. Primary completion A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04953117

  14. Study start Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05389254

  15. Primary completion The Multicenter Clinical Trial of a Novel TEER Decive (V-CLASP Trial) Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05391802

  16. Study start The Multicenter Clinical Trial of a Novel TEER Decive (V-CLASP Trial) Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05391802

  17. Study completion Intervention for Monitoring of Salt Intake in Hypertensive Patients Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05397054

  18. Study start A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05417945

  19. Study start Safety and Efficacy Study Of The Thoracic Aortic Stent Graft System Treating Aortic Dissection Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05430672

  20. Study start Home-based Remote Monitoring Registry record

    Expected 2022-07-01; that period ended on 2022-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05295303

  21. Study start The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2022-07-01; that period ended on 2022-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05426018

  22. Study start Effects of Individualized Accurate Positioning TMS Based on Task fMRI Activation on Upper Extremity Function After Stroke Registry record

    Expected 2022-07-01; that period ended on 2022-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05440292

  23. Primary completion The Prehospital Administration of Normobaric Oxygen in Suspected Stroke Registry record

    Expected 2022-07-20; that period ended on 2022-07-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05351073

  24. Study start Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions Registry record

    Expected 2022-07-26; that period ended on 2022-07-26.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05354297

  25. Primary completion WEDGES: Coronary Lesion Preparation With Enhanced Dilatation for Good Expansion of Stent: Assessment of a New Scoring Balloon by Quantitative Stent Enhanced Visualization Registry record

    Expected 2022-07-30; that period ended on 2022-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05019443

  26. Primary completion ROBOtic Care of Post-stroke Pain. Registry record

    Expected 2022-07-30; that period ended on 2022-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05288270

  27. Primary completion Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI Registry record

    Expected 2022-07; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02323620

  28. Primary completion A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve Registry record

    Expected 2022-07; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02434263

  29. Study completion Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction Registry record

    Expected 2022-07; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03041259

  30. Study completion Non-invasive Point-of-care Diagnosis Using Machine Learning and Signal Analytics to Transform Early Detection of Heart Disease Registry record

    Expected 2022-07; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03864081

  31. Primary completion Non-invasive Point-of-care Diagnosis Using Machine Learning and Signal Analytics to Transform Early Detection of Heart Disease Registry record

    Expected 2022-07; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03864081

  32. Study completion Multimodal Biomarkers for Diagnosis and Prognosis in CAA Registry record

    Expected 2022-07-31; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03969732

  33. Primary completion Multimodal Biomarkers for Diagnosis and Prognosis in CAA Registry record

    Expected 2022-07-31; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03969732

  34. Study completion SaeboGlove Therapy for Severe Upper Limb Disability and Severe Hand Impairment After Stroke Registry record

    Expected 2022-07; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04007315

  35. Primary completion SaeboGlove Therapy for Severe Upper Limb Disability and Severe Hand Impairment After Stroke Registry record

    Expected 2022-07; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04007315

  36. Primary completion A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Registry record

    Expected 2022-07; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04179045

  37. Study completion The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation Registry record

    Expected 2022-07-31; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04217135

  38. Primary completion The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation Registry record

    Expected 2022-07-31; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04217135

  39. Study completion Implementing Standards of Care for Heart Failure Patients in General Practice - A Regional Disease Management Program Registry record

    Expected 2022-07-31; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04334447

  40. Primary completion Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury Registry record

    Expected 2022-07-31; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04493840

  41. Primary completion Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft Registry record

    Expected 2022-07; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04735965

  42. Study completion Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus Registry record

    Expected 2022-07; that period ended on 2022-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04817215

  43. Study start Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension. Registry record

    Expected 2022-08-01; that period ended on 2022-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05110898

  44. Study start Comparison of Peri-procedural Complications of Intracardiac Echocardiography and Transesophageal Echocardiography in Patients With Atrial Fibrillation Registry record

    Expected 2022-08-01; that period ended on 2022-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05466266

  45. Study start Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting Registry record

    Expected 2022-08-27; that period ended on 2022-08-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04904250

  46. Primary completion Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial Registry record

    Expected 2022-08-30; that period ended on 2022-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04696120

  47. Study completion Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers Registry record

    Expected 2022-08; that period ended on 2022-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02618837

  48. Study completion Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension Registry record

    Expected 2022-08; that period ended on 2022-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03254446

  49. Study completion Coronary Revascularization Versus Conservative Therapy in Patients With Treated Critical Limb Ischemia Registry record

    Expected 2022-08-31; that period ended on 2022-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03712644

  50. Primary completion First in Men Study: BIOMAG-I Registry record

    Expected 2022-08; that period ended on 2022-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04157153

  51. Study completion Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury Registry record

    Expected 2022-08-31; that period ended on 2022-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04493840

  52. Study completion Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds Registry record

    Expected 2022-08; that period ended on 2022-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04504864

  53. Study completion 3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI Registry record

    Expected 2022-08; that period ended on 2022-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04570345

  54. Study completion Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft Registry record

    Expected 2022-08; that period ended on 2022-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04735965

  55. Study start To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart Failure Registry record

    Expected 2022-08; that period ended on 2022-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05486000

  56. Study start The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis Registry record

    Expected 2022-09-01; that period ended on 2022-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04981327

  57. Study start Henagliflozin in Patients With Atrial Fibrillation Registry record

    Expected 2022-09-01; that period ended on 2022-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05252624

  58. Primary completion Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI in Patients With Residual Non-flow Limiting Lesions Registry record

    Expected 2022-09-15; that period ended on 2022-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03857971

  59. Primary completion Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients Registry record

    Expected 2022-09-23; that period ended on 2022-09-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04932928

  60. Primary completion Remote Magnetic Versus Manual Navigation-guided Ablation for Non-outflow Tract Premature Ventricular Contractions: a Prospective, Randomized, Controlled Trial Registry record

    Expected 2022-09-30; that period ended on 2022-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04519112

  61. Primary completion An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II) Registry record

    Expected 2022-09-30; that period ended on 2022-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04524624

  62. Primary completion Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy Registry record

    Expected 2022-09; that period ended on 2022-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04667143

  63. Primary completion Study of Roxadustat in the Treatment of Acute Myocardial Infarction Registry record

    Expected 2022-09-30; that period ended on 2022-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04803864

  64. Study start Safety and Effectiveness of Left Bundle Branch Pacing in Patients With Cardiac Dysfunction and AV Block Registry record

    Expected 2022-09; that period ended on 2022-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05553626

  65. Primary completion Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction Registry record

    Expected 2022-10-01; that period ended on 2022-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04063345

  66. Primary completion Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting Registry record

    Expected 2022-10-01; that period ended on 2022-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04898569

  67. Primary completion Clinical Of Chocolate Balloon Dilatation Versus Plain Balloon Dilatation to Treat Arteriosclerosis Occlusive Disease of Lower Extremity Registry record

    Expected 2022-10-01; that period ended on 2022-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05158283

  68. Study start Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease Registry record

    Expected 2022-10-01; that period ended on 2022-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05203484

  69. Study start Prophylactic Effects of Agomelatine for Poststroke Depression Registry record

    Expected 2022-10-01; that period ended on 2022-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05426304

  70. Study start AI Health Assistant and Type 2 Diabetes Registry record

    Expected 2022-10-01; that period ended on 2022-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05539066

  71. Study completion AUSTrian Randomized Interventional Study on Dialysis Accesses Registry record

    Expected 2022-10-04; that period ended on 2022-10-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03764358

  72. Primary completion Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery Registry record

    Expected 2022-10-10; that period ended on 2022-10-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05079672

  73. Study start Clinical Trial in China Registry record

    Expected 2022-10-14; that period ended on 2022-10-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05580952

  74. Primary completion S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients. Registry record

    Expected 2022-10-15; that period ended on 2022-10-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04457323

  75. Study start Prediabetes Management Registry record

    Expected 2022-10-17; that period ended on 2022-10-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05531838

  76. Study completion The Prehospital Administration of Normobaric Oxygen in Suspected Stroke Registry record

    Expected 2022-10-20; that period ended on 2022-10-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05351073

  77. Primary completion Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility Registry record

    Expected 2022-10-20; that period ended on 2022-10-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05407207

  78. Study completion WEDGES: Coronary Lesion Preparation With Enhanced Dilatation for Good Expansion of Stent: Assessment of a New Scoring Balloon by Quantitative Stent Enhanced Visualization Registry record

    Expected 2022-10-30; that period ended on 2022-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05019443

  79. Primary completion Robot-Enhanced Stroke Therapy Optimizes Rehabilitation (RESTORE) Registry record

    Expected 2022-10; that period ended on 2022-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04201613

  80. Primary completion Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke Registry record

    Expected 2022-10-31; that period ended on 2022-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04415164

  81. Primary completion Impact of Vitamin C on Biomarkers of Neurologic Injury in Survivors of Cardiac Arrest Registry record

    Expected 2022-10-31; that period ended on 2022-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04563000

  82. Study completion Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy Registry record

    Expected 2022-10; that period ended on 2022-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04667143

  83. Primary completion Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction Registry record

    Expected 2022-10; that period ended on 2022-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05060588

  84. Study completion To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin Registry record

    Expected 2022-10-31; that period ended on 2022-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05101135

  85. Primary completion To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin Registry record

    Expected 2022-10-31; that period ended on 2022-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05101135

  86. Primary completion Assessment of Intracerebral Hematoma Registry record

    Expected 2022-10; that period ended on 2022-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05158660

  87. Primary completion Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients Registry record

    Expected 2022-10-31; that period ended on 2022-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05226897

  88. Primary completion Rivaroxaban or Aspirin for Biological Aortic Prosthesis Registry record

    Expected 2022-11-01; that period ended on 2022-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02974920

  89. Study start The Safety and Long-Term Clinical Benefit of PCSK9i in STEMI Patients Registry record

    Expected 2022-11-01; that period ended on 2022-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05579418

  90. Study completion Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility Registry record

    Expected 2022-11-11; that period ended on 2022-11-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05407207

  91. Study start Effect of Dapagliflozin on VT in Patients With Heart Failure. Registry record

    Expected 2022-11-15; that period ended on 2022-11-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05550441

  92. Study completion Stitch Closure of PFO and Septal Repair Registry record

    Expected 2022-11-20; that period ended on 2022-11-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03373929

  93. Study completion Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF Registry record

    Expected 2022-11-21; that period ended on 2022-11-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05487365

  94. Primary completion Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF Registry record

    Expected 2022-11-21; that period ended on 2022-11-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05487365

  95. Study completion To Evaluate The Safety and Efficacy of AVI Stent Comparing With Firebird2® For Treating Coronary Revascularization Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02133287

  96. Study completion Early Sleep Apnea Treatment in Stroke Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02554487

  97. Study completion Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02579499

  98. Primary completion Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02579499